The technology has been awarded multiple grant and equity funding awards (PI of award).

  • Texas Emerging Technology Fund
  • NIH five year collaborative award with leading academic institutions (Dr. Hook)
  • U.T. M. D. Anderson Cancer Center MRP Award (Dr. Dickey)
  • AlphaDev partnership
  • “Living Legends” fund (Dr. Dickey)
  • Culpeper award (Dr. Evans)
  • NCI Leukemia SPORE grant (Dr. Evans)
  • Inaugural Texas Ignition Fund award
  • Lehman Brothers Foundation award (Dr. Dickey)
  • NHLBI  R01 on mechanisms of inducible resistance (Dr. Evans)
  • NHLBI/Office of the Director New Innovator Award (Dr. Evans)
  • TJ Martell Foundation on mechanisms of inducible resistance (Dr. Evans)
  • U.T. M. D. Anderson Cancer Center – Technology Review Committee
  • Five NIH SBIR awards (Dr. Scott)
  • Cancer Prevention Research Institute of Texas (Dr. Scott)